ArrowMark Colorado Holdings’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-410,797
Closed -$19.1M 333
2023
Q2
$19.1M Sell
410,797
-1,412
-0.3% -$65.6K 0.21% 99
2023
Q1
$11.8M Sell
412,209
-2,622
-0.6% -$75.1K 0.13% 127
2022
Q4
$12.9M Sell
414,831
-216,302
-34% -$6.75M 0.15% 117
2022
Q3
$12.8M Buy
631,133
+11,700
+2% +$237K 0.16% 122
2022
Q2
$9.61M Buy
619,433
+170,599
+38% +$2.65M 0.11% 167
2022
Q1
$8.59M Buy
448,834
+23,737
+6% +$454K 0.08% 205
2021
Q4
$10.8M Buy
425,097
+14,664
+4% +$371K 0.09% 187
2021
Q3
$13.4M Buy
+410,433
New +$13.4M 0.11% 163